Projects funded by the NCN
Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies
2016/21/B/NZ7/02041
Keywords:
B cell malignancies therapy non-Hodgkin lymphoma chronic lymphoblastic leukemia thioredoxin reductase
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ5_7: Human disease treatment
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Warszawski Uniwersytet Medyczny, Wydział Lekarski
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 11 - announced on 2016-03-15
Amount awarded: 1 386 300 PLN
Project start date (Y-m-d): 2017-03-06
Project end date (Y-m-d): 2020-03-05
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.